WA Biotech Firms Develop RNA Therapies for Diabetes

Western Australian biotech companies ProGenis and Syngenis Laboratories are developing RNA-based therapies to advance diabetes treatment, aiming to go beyond current options like Ozempic. They are also establishing Australia's first RNA facility to support this innovative research.

Read the full story at Sydney Morning Herald→